{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T04:04:54Z","timestamp":1745294694180,"version":"3.40.4"},"posted":{"date-parts":[[2025,4,18]]},"group-title":"In Review","reference-count":95,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,4,16]]},"abstract":"<title>Abstract<\/title>\n        <p>Converging evidence suggests that erythropoietin (Epo) may be effective in alleviating symptoms of many neurological conditions, including traumatic brain injury and neurodegenerative disorders. However, a limitation to its use as a therapeutic agent is the risk associated with stimulation of hematopoietic pathways. To overcome this issue, we used a recombinant adeno-associated viral vector (AAV) designed to express a modified form of erythropoietin devoid of hematopoietic activity, EpoR76E. Our previous research showed that AAV.EpoR76E prevented motor impairments and mitigated loss of dopaminergic neurons in the MPTP mouse model of Parkinson\u2019s disease. In the present study, a single intramuscular injection of AAV expressing EpoR76E prevented cognitive decline in the 5xFAD transgenic model of Alzheimer\u2019s disease. Consistent with this, AAV-EpoR76E prevented the age-related loss of pre- and post-synaptic proteins synaptophysin and PSD-95 normally seen in 5xFAD transgenics. Additionally, the treatment reduced soluble and aggregated amyloid-\u03b2 levels in 5xFAD mice, and prevented the loss of neurons in the medial septum and vertical limb of the diagonal band, the primary cholinergic projections to the hippocampus. Together, these results suggest that AAV-EpoR76E might represent a novel therapeutic approach for Alzheimer\u2019s disease and other neurodegenerative disorders.<\/p>","DOI":"10.21203\/rs.3.rs-6465973\/v1","type":"posted-content","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T07:25:36Z","timestamp":1744961136000},"source":"Crossref","is-referenced-by-count":0,"title":["Intramuscular delivery of recombinant AAV expressing EpoR76E improves memory and is neuroprotective in 5xFAD transgenics"],"prefix":"10.21203","author":[{"given":"John","family":"Killmar","sequence":"first","affiliation":[{"name":"University of Tennessee Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xue","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruishan","family":"Wang","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonia","family":"Rex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca-Fang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9642-964X","authenticated-orcid":false,"given":"Michael","family":"McDonald","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"5054","key":"ref1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy JA","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"year":"2011","author":"Armstrong RA","key":"ref2","unstructured":"Armstrong RA. (2011). The pathogenesis of Alzheimer's disease: a reevaluation of the amyloid cascade hypothesis. International journal of Alzheimer's disease, 2011, 630865."},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","article-title":"Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony","volume":"40","author":"Forner S","year":"2017","unstructured":"Forner S, Baglietto-Vargas D, Martini AC, Trujillo-Estrada L, LaFerla FM. Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony. Trends Neurosci. 2017;40(6):347\u201357.","journal-title":"Trends Neurosci"},{"year":"2015","author":"Heneka MT","key":"ref4","unstructured":"Heneka MT, Carson MJ, Khoury E, Landreth J, Brosseron GE, Feinstein F, Jacobs DL, Wyss-Coray AH, Vitorica T, Ransohoff J, Herrup RM, Frautschy K, Finsen SA, Brown B, Verkhratsky GC, Yamanaka A, Koistinaho K, Latz J, Halle E, Petzold A, Town GC, Morgan T, Shinohara D, Perry ML, Holmes VH, Bazan C, Brooks NG, Hunot DJ, Joseph S, Deigendesch B, Garaschuk N, Boddeke O, Dinarello E, Breitner CA, Cole JC, G. M., Golenbock, D. T., Kummer MP. (2015). Neuroinflammation in Alzheimer's disease. Lancet neurology, 14(4), 388\u2013405."},{"year":"2012","author":"Weintraub S","key":"ref5","unstructured":"Weintraub S, Wicklund AH, Salmon DP. (2012). The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med, 2(4), a006171."},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.critrevonc.2007.06.006","article-title":"Pathophysiology of anemia and erythrocytosis","volume":"64","author":"Hodges VM","year":"2007","unstructured":"Hodges VM, Rainey S, Lappin TR, Maxwell AP. Pathophysiology of anemia and erythrocytosis. Crit Rev Oncol\/Hematol. 2007;64(2):139\u201358.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0306-4522(96)00306-5","article-title":"Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death","volume":"76","author":"Morishita E","year":"1997","unstructured":"Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76(1):105\u201316.","journal-title":"Neuroscience"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","article-title":"In vivo evidence that erythropoietin protects neurons from ischemic damage","volume":"95","author":"Sakanaka M","year":"1998","unstructured":"Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA. 1998;95(8):4635\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3\u20134","key":"ref9","first-page":"228","article-title":"The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential","volume":"79","author":"Dame C","year":"2001","unstructured":"Dame C, Juul SE, Christensen RD. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate. 2001;79(3\u20134):228\u201335.","journal-title":"Biol Neonate"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/2277-9175.100157","article-title":"Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease","volume":"1","author":"Arabpoor Z","year":"2012","unstructured":"Arabpoor Z, Hamidi G, Rashidi B, Shabrang M, Alaei H, Sharifi MR, Salami M, Dolatabadi HR, Reisi P. Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease. Adv Biomed Res. 2012;1:50.","journal-title":"Adv Biomed Res"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00004647-199906000-00007","article-title":"A potential role for erythropoietin in focal permanent cerebral ischemia in mice","volume":"19","author":"Bernaudin M","year":"1999","unstructured":"Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab. 1999;19(6):643\u201351.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17219\/acem\/61044","article-title":"Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats","volume":"26","author":"Cevik B","year":"2017","unstructured":"Cevik B, Solmaz V, Yigitturk G, Cavusoglu T, Peker G, Erbas O. Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats. Adv Clin Exp Med. 2017;26(1):23\u20139.","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1471-4159.2011.07534.x","article-title":"Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models","volume":"120","author":"Lee ST","year":"2012","unstructured":"Lee ST, Chu K, Park JE, Jung KH, Jeon D, Lim JY, Lee SK, Kim M, Roh JK. Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models. J Neurochem. 2012;120(1):115\u201324.","journal-title":"J Neurochem"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/gt.2009.113","article-title":"AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease","volume":"17","author":"Xue YQ","year":"2010","unstructured":"Xue YQ, Ma BF, Zhao LR, Tatom JB, Li B, Jiang LX, Klein RL, Duan WM. AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease. Gene Ther. 2010;17(1):83\u201394.","journal-title":"Gene Ther"},{"year":"2017","author":"Zhou J","key":"ref15","unstructured":"Zhou J, Li J, Rosenbaum DM, Zhuang J, Poon C, Qin P, Rivera K, Lepore J, Willette RN, Hu E, Barone FC. (2017). The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits. PloS one, 12(9), e0184049."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fneur.2018.00451","article-title":"Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats","volume":"9","author":"Robinson S","year":"2018","unstructured":"Robinson S, Winer JL, Chan LAS, Oppong AY, Yellowhair TR, Maxwell JR, Andrews N, Yang Y, Sillerud LO, Meehan WP 3rd, Mannix R, Brigman JL, Jantzie LL. Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats. Front Neurol. 2018;9:451.","journal-title":"Front Neurol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrn1687","article-title":"Emerging biological roles for erythropoietin in the nervous system","volume":"6","author":"Brines M","year":"2005","unstructured":"Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6(6):484\u201394.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12017-019-08524-y","article-title":"The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease","volume":"21","author":"Sun J","year":"2019","unstructured":"Sun J, Martin JM, Vanderpoel V, Sumbria RK. The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease. Neuromolecular Med. 2019;21(1):12\u201324.","journal-title":"Neuromolecular Med"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","article-title":"Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system","volume":"6","author":"Sir\u00e9n AL","year":"2009","unstructured":"Sir\u00e9n AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6(1):108\u201327.","journal-title":"Neurotherapeutics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/bs.apcsb.2018.01.007","article-title":"Peptide Derivatives of Erythropoietin in the Treatment of Neuroinflammation and Neurodegeneration","volume":"112","author":"Ercan I","year":"2018","unstructured":"Ercan I, Tufekci KU, Karaca E, Genc S, Genc K. Peptide Derivatives of Erythropoietin in the Treatment of Neuroinflammation and Neurodegeneration. Adv Protein Chem Struct Biol. 2018;112:309\u201357.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.4103\/1673-5374.284994","article-title":"Targeting the transferrin receptor to develop erythropoietin for Alzheimer's disease","volume":"15","author":"Sumbria RK","year":"2020","unstructured":"Sumbria RK. Targeting the transferrin receptor to develop erythropoietin for Alzheimer's disease. Neural Regen Res. 2020;15(12):2251\u20132.","journal-title":"Neural Regen Res"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13195-023-01356-w","article-title":"NeuroEPO plus (NeuralCIM((R))) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial","volume":"15","author":"Sosa S","year":"2023","unstructured":"Sosa S, Bringas G, Urrutia N, Penalver AI, Lopez D, Gonzalez E, Fernandez A, Hernandez ZM, Vina A, Pena Y, Batista JF, Valenzuela C, Leon K, Crombet T, Rodriguez T, Perez L, Investigators A. NeuroEPO plus (NeuralCIM((R))) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial. Alzheimers Res Ther. 2023;15(1):215.","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1089\/hum.2011.052","article-title":"Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA\/2J glaucomatous mice","volume":"22","author":"Sullivan TA","year":"2011","unstructured":"Sullivan TA, Geisert EE, Hines-Beard J, Rex TS. Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA\/2J glaucomatous mice. Hum Gene Ther. 2011;22(10):1191\u2013200.","journal-title":"Hum Gene Ther"},{"year":"2023","author":"Naguib S","key":"ref24","unstructured":"Naguib S, DeJulius CR, Backstrom JR, Haider AA, Ang JM, Boal AM, Calkins DJ, Duvall CL, Rex TS. (2023). Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2\/ARE Pathway. Antioxidants (Basel), 12(3)."},{"year":"2021","author":"Biswal MR","key":"ref25","unstructured":"Biswal MR, Wang Z, Paulson RJ, Uddin RR, Tong Y, Zhu P, Li H, Lewin AS. (2021). Erythropoietin Gene Therapy Delays Retinal Degeneration Resulting from Oxidative Stress in the Retinal Pigment Epithelium. Antioxidants (Basel), 10(6)."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jconrel.2020.10.010","article-title":"Microsphere antioxidant and sustained erythropoietin-R76E release functions cooperate to reduce traumatic optic neuropathy","volume":"329","author":"DeJulius CR","year":"2021","unstructured":"DeJulius CR, Bernardo-Colon A, Naguib S, Backstrom JR, Kavanaugh T, Gupta MK, Duvall CL, Rex TS. Microsphere antioxidant and sustained erythropoietin-R76E release functions cooperate to reduce traumatic optic neuropathy. J Control Release. 2021;329:762\u201373.","journal-title":"J Control Release"},{"year":"2016","author":"Rex TS","key":"ref27","unstructured":"Rex TS, Kasmala L, Bond WS, de Lucas Cerrillo AM, Wynn K, Lewin AS. (2016). Erythropoietin Slows Photoreceptor Cell Death in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa. PloS one, 11(6), e0157411."},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/OPX.0000000000000898","article-title":"Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing","volume":"94","author":"Bricker-Anthony C","year":"2017","unstructured":"Bricker-Anthony C, D'Surney L, Lunn B, Hines-Beard J, Jo M, Bernardo-Colon A, Rex TS. Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing. Optom Vis Sci. 2017;94(1):20\u201332.","journal-title":"Optom Vis Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12974-016-0499-5","article-title":"Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress","volume":"13","author":"Hines-Beard J","year":"2016","unstructured":"Hines-Beard J, Bond WS, Backstrom JR, Rex TS. Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress. J Neuroinflamm. 2016;13:39.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exer.2012.01.006","article-title":"Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin","volume":"96","author":"Sullivan TA","year":"2012","unstructured":"Sullivan TA, Geisert EE, Templeton JP, Rex TS. Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin. Exp Eye Res. 2012;96(1):36\u201341.","journal-title":"Exp Eye Res"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/gbb.12001","article-title":"A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism","volume":"12","author":"Dhanushkodi A","year":"2013","unstructured":"Dhanushkodi A, Akano EO, Roguski EE, Xue Y, Rao SK, Matta SG, Rex TS, McDonald MP. A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism. Genes Brain Behav. 2013;12(2):224\u201333.","journal-title":"Genes Brain Behav"},{"issue":"40","key":"ref32","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley H","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","article-title":"Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model","volume":"33","author":"Kimura R","year":"2009","unstructured":"Kimura R, Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis. 2009;33(2):229\u201335.","journal-title":"Neurobiol Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-8-2","article-title":"Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation","volume":"8","author":"Eimer WA","year":"2013","unstructured":"Eimer WA, Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation. Mol neurodegeneration. 2013;8:2.","journal-title":"Mol neurodegeneration"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/gbb.12133","article-title":"Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics","volume":"13","author":"Flanigan TJ","year":"2014","unstructured":"Flanigan TJ, Xue Y, Kishan Rao S, Dhanushkodi A, McDonald MP. Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. Genes Brain Behav. 2014;13(5):488\u2013500.","journal-title":"Genes Brain Behav"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/15665232113139990024","article-title":"Identification of a therapeutic dose of continuously delivered erythropoietin in the eye using an inducible promoter system","volume":"13","author":"Hines-Beard J","year":"2013","unstructured":"Hines-Beard J, Desai S, Haag R, Esumi N, D'Surney L, Parker S, Richardson C, Rex TS. Identification of a therapeutic dose of continuously delivered erythropoietin in the eye using an inducible promoter system. Curr Gene Ther. 2013;13(4):275\u201381.","journal-title":"Curr Gene Ther"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11064-010-0272-6","article-title":"Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse","volume":"36","author":"Sullivan T","year":"2011","unstructured":"Sullivan T, Rex TS. Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse. Neurochem Res. 2011;36(4):613\u20138.","journal-title":"Neurochem Res"},{"key":"ref38","first-page":"1236","article-title":"The distribution, concentration, and toxicity of enhanced green fluorescent protein in retinal cells after genomic or somatic (virus-mediated) gene transfer","volume":"11","author":"Rex TS","year":"2005","unstructured":"Rex TS, Peet JA, Surace EM, Calvert PD, Nikonov SS, Lyubarsky AL, Bendo E, Hughes T, Pugh EN Jr., Bennett J. The distribution, concentration, and toxicity of enhanced green fluorescent protein in retinal cells after genomic or somatic (virus-mediated) gene transfer. Mol Vis. 2005;11:1236\u201345.","journal-title":"Mol Vis"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13816810701503707","article-title":"Rescue of sight by gene therapy - closer than it may appear","volume":"28","author":"Rex TS","year":"2007","unstructured":"Rex TS. Rescue of sight by gene therapy - closer than it may appear. Ophthalmic Genet. 2007;28(3):127\u201333.","journal-title":"Ophthalmic Genet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-0-387-74904-4_16","article-title":"Virus-mediated gene delivery to neuronal progenitors","volume":"613","author":"Rex TS","year":"2008","unstructured":"Rex TS. Virus-mediated gene delivery to neuronal progenitors. Adv Exp Med Biol. 2008;613:147\u201353.","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1089\/hum.2004.15.960","article-title":"Adenovirus-mediated delivery of catalase to retinal pigment epithelial cells protects neighboring photoreceptors from photo-oxidative stress","volume":"15","author":"Rex TS","year":"2004","unstructured":"Rex TS, Tsui I, Hahn P, Maguire AM, Duan D, Bennett J, Dunaief JL. Adenovirus-mediated delivery of catalase to retinal pigment epithelial cells protects neighboring photoreceptors from photo-oxidative stress. Hum Gene Ther. 2004;15(10):960\u20137.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/104303401450988","article-title":"Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column","volume":"12","author":"Auricchio A","year":"2001","unstructured":"Auricchio A, Hildinger M, O'Connor E, Gao GP, Wilson JM. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther. 2001;12(1):71\u20136.","journal-title":"Hum Gene Ther"},{"issue":"16","key":"ref43","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1074\/jbc.270.16.9564","article-title":"Aggregation of secreted amyloid \u03b2-protein into sodium dodecyl sulfate-stable oligomers in cell culture","volume":"270","author":"Podlisny MB","year":"1995","unstructured":"Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, Selkoe DJ. Aggregation of secreted amyloid \u03b2-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem. 1995;270(16):9564\u201370.","journal-title":"J Biol Chem"},{"issue":"3","key":"ref44","article-title":"Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression","volume":"9","author":"Li JJ","year":"2014","unstructured":"Li JJ, Dolios G, Wang R, Liao FF. (2014). Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression. PLoS ONE, 9(3), e90770.","journal-title":"PLoS ONE"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/gbb.12377","article-title":"Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration","volume":"16","author":"Akkhawattanangkul Y","year":"2017","unstructured":"Akkhawattanangkul Y, Maiti P, Xue Y, Aryal D, Wetsel WC, Hamilton D, Fowler SC, McDonald MP. Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration. Genes Brain Behav. 2017;16(5):522\u201336.","journal-title":"Genes Brain Behav"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2018.10.038","article-title":"Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration","volume":"692","author":"Dhanushkodi A","year":"2019","unstructured":"Dhanushkodi A, Xue Y, Roguski EE, Ding Y, Matta SG, Heck D, Fan GH, McDonald MP. Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration. Neurosci Lett. 2019;692:53\u201363.","journal-title":"Neurosci Lett"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/147683009X423364","article-title":"Antioxidants and cognitive training interact to affect oxidative stress and memory in APP\/PSEN1 mice","volume":"12","author":"Harrison FE","year":"2009","unstructured":"Harrison FE, Allard J, Bixler R, Usoh C, Li L, May JM, McDonald MP. Antioxidants and cognitive training interact to affect oxidative stress and memory in APP\/PSEN1 mice. Nutr Neurosci. 2009;12(5):203\u201318.","journal-title":"Nutr Neurosci"},{"year":"2011","author":"Dhanushkodi A","key":"ref48","unstructured":"Dhanushkodi A, McDonald MP. (2011). Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration. PloS one, 6(12), e29285."},{"key":"ref49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/B978-0-12-405195-9.00023-8","volume-title":"Movement Disorders: Genetics and Models","author":"McDonald MP","year":"2015","unstructured":"McDonald MP. Methods and models of the non-motor symptoms of Parkinson disease. In: LeDoux MS, editor. Movement Disorders: Genetics and Models. 2nd ed. Amsterdam: Elsevier Academic; 2015. pp. 387\u2013412.","edition":"2"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0149-7634(97)00024-9","article-title":"Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's disease","volume":"22","author":"McDonald MP","year":"1998","unstructured":"McDonald MP, Overmier JB. Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's disease. Neurosci Biobehav Rev. 1998;22(1):99\u2013120.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1037\/0735-7044.110.5.1025","article-title":"Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed-nonmatching-to-position task","volume":"110","author":"McDonald MP","year":"1996","unstructured":"McDonald MP, Crawley JN. Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed-nonmatching-to-position task. Behav Neurosci. 1996;110(5):1025\u201332.","journal-title":"Behav Neurosci"},{"issue":"13","key":"ref52","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1523\/JNEUROSCI.18-13-05078.1998","article-title":"Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions","volume":"18","author":"McDonald MP","year":"1998","unstructured":"McDonald MP, Willard LB, Wenk GL, Crawley JN. Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions. J Neurosci. 1998;18(13):5078\u201385.","journal-title":"J Neurosci"},{"year":"2016","author":"Leach PT","key":"ref53","unstructured":"Leach PT, Hayes J, Pride M, Silverman JL, Crawley JN. (2016). Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task. eNeuro, 3(1)."},{"year":"2010","author":"Devi L","key":"ref54","unstructured":"Devi L, Ohno M. (2010). Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PloS one, 5(9), e12974."},{"year":"2012","author":"Jawhar S","key":"ref55","unstructured":"Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O. (2012). Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiology of Aging, 33(1), 196 e129-140."},{"issue":"7","key":"ref56","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1007\/s12035-022-02839-x","article-title":"Direct AT2R Stimulation Slows Post-stroke Cognitive Decline in the 5XFAD Alzheimer's Disease Mice","volume":"59","author":"Ahmed HA","year":"2022","unstructured":"Ahmed HA, Ismael S, Salman M, Devlin P, McDonald MP, Liao FF, Ishrat T. Direct AT2R Stimulation Slows Post-stroke Cognitive Decline in the 5XFAD Alzheimer's Disease Mice. Mol Neurobiol. 2022;59(7):4124\u201340.","journal-title":"Mol Neurobiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/BCI.S13025","article-title":"Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis","volume":"6","author":"Maarouf CL","year":"2013","unstructured":"Maarouf CL, Kokjohn TA, Whiteside CM, Macias MP, Kalback WM, Sabbagh MN, Beach TG, Vassar R, Roher AE. Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis. Biochem Insights. 2013;6:1\u201310.","journal-title":"Biochem Insights"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2011.09.014","article-title":"Viral vectors for gene delivery to the central nervous system","volume":"48","author":"Lentz TB","year":"2012","unstructured":"Lentz TB, Gray SJ, Samulski RJ. Viral vectors for gene delivery to the central nervous system. Neurobiol Dis. 2012;48(2):179\u201388.","journal-title":"Neurobiol Dis"},{"issue":"11","key":"ref59","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1089\/hum.2017.160","article-title":"Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future","volume":"28","author":"Piguet F","year":"2017","unstructured":"Piguet F, Alves S, Cartier N. Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future. Hum Gene Ther. 2017;28(11):988\u20131003.","journal-title":"Hum Gene Ther"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/gt.2015.12","article-title":"Safety and angiogenic effects of systemic gene delivery of a modified erythropoietin","volume":"22","author":"Cerrillo L","year":"2015","unstructured":"de Cerrillo L, Bond AM, W. S., Rex TS. Safety and angiogenic effects of systemic gene delivery of a modified erythropoietin. Gene Ther. 2015;22(5):365\u201373.","journal-title":"Gene Ther"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3233\/JAD-141389","article-title":"Memory Improvement in the AbetaPP\/PS1 Mouse Model of Familial Alzheimer's Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes","volume":"45","author":"Armand-Ugon M","year":"2015","unstructured":"Armand-Ugon M, Aso E, Moreno J, Riera-Codina M, Sanchez A, Vegas E, Ferrer I. Memory Improvement in the AbetaPP\/PS1 Mouse Model of Familial Alzheimer's Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes. J Alzheimer's disease: JAD. 2015;45(2):407\u201321.","journal-title":"J Alzheimer's disease: JAD"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pathophys.2013.01.001","article-title":"Erythropoietin improves spatial learning and memory in streptozotocin model of dementia","volume":"20","author":"Hamidi G","year":"2013","unstructured":"Hamidi G, Arabpour Z, Shabrang M, Rashidi B, Alaei H, Sharifi MR, Salami M, Reisi P. Erythropoietin improves spatial learning and memory in streptozotocin model of dementia. Pathophysiology. 2013;20(2):153\u20138.","journal-title":"Pathophysiology"},{"issue":"5","key":"ref63","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4196\/kjpp.2010.14.5.345","article-title":"Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia","volume":"14","author":"Kumar R","year":"2010","unstructured":"Kumar R, Jaggi AS, Singh N. Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia. Korean J Physiol Pharmacol. 2010;14(5):345\u201352.","journal-title":"Korean J Physiol Pharmacol"},{"issue":"11","key":"ref64","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/0269881113494939","article-title":"Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Abeta(2)(5)(-)(3)(5) non-transgenic mouse model of Alzheimer's disease","volume":"27","author":"Maurice T","year":"2013","unstructured":"Maurice T, Mustafa MH, Desrumaux C, Keller E, Naert G, de la CG-BM, Cruz R, Y., Garcia Rodriguez JC. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Abeta(2)(5)(-)(3)(5) non-transgenic mouse model of Alzheimer's disease. J Psychopharmacol. 2013;27(11):1044\u201357.","journal-title":"J Psychopharmacol"},{"issue":"5868","key":"ref65","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris RG","year":"1982","unstructured":"Morris RG, Garrud P, Rawlins JN, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 1982;297(5868):681\u20133.","journal-title":"Nature"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2006.03.042","article-title":"Hippocampal lesions impair performance on a conditional delayed matching and non-matching to position task in the rat","volume":"171","author":"Sloan HL","year":"2006","unstructured":"Sloan HL, Dobrossy M, Dunnett SB. Hippocampal lesions impair performance on a conditional delayed matching and non-matching to position task in the rat. Behav Brain Res. 2006;171(2):240\u201350.","journal-title":"Behav Brain Res"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2006.03.030","article-title":"Double dissociation between hippocampal and prefrontal lesions on an operant delayed matching task and a water maze reference memory task","volume":"171","author":"Sloan HL","year":"2006","unstructured":"Sloan HL, Good M, Dunnett SB. Double dissociation between hippocampal and prefrontal lesions on an operant delayed matching task and a water maze reference memory task. Behav Brain Res. 2006;171(1):116\u201326.","journal-title":"Behav Brain Res"},{"year":"1998","author":"Paule MG","key":"ref68","unstructured":"Paule MG, Bushnell PJ, Maurissen JP, Wenger GR, Buccafusco JJ, Chelonis JJ, Elliott R. (1998). Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicology and Teratology, 20(5), 493\u2013502."},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0091-3057(95)00116-E","article-title":"Triazolam in Alzheimer's disease: pilot study on sleep and memory effects","volume":"52","author":"McCarten JR","year":"1995","unstructured":"McCarten JR, Kovera C, Maddox MK, Cleary JP. Triazolam in Alzheimer's disease: pilot study on sleep and memory effects. Pharmacol Biochem Behav. 1995;52(2):447\u201352.","journal-title":"Pharmacol Biochem Behav"},{"issue":"7\u20138","key":"ref70","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.neuropharm.2010.12.018","article-title":"The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques","volume":"60","author":"Malkova L","year":"2011","unstructured":"Malkova L, Kozikowski AP, Gale K. The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques. Neuropharmacology. 2011;60(7\u20138):1262\u20138.","journal-title":"Neuropharmacology"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpsycho.2012.08.002","article-title":"Gamma oscillatory activity in relation to memory ability in older adults","volume":"86","author":"Park JY","year":"2012","unstructured":"Park JY, Lee KS, An SK, Lee J, Kim JJ, Kim KH, Namkoong K. Gamma oscillatory activity in relation to memory ability in older adults. Int J Psychophysiol. 2012;86(1):58\u201365.","journal-title":"Int J Psychophysiol"},{"issue":"6","key":"ref72","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/13825585.2020.1826898","article-title":"Delayed matching to sample task 48: assessment of malingering with simulating design","volume":"28","author":"Nikolai T","year":"2021","unstructured":"Nikolai T, Cechova K, Bukacova K, Fendrych Mazancova A, Markova H, Bezdicek O, Hort J, Vyhnalek M. Delayed matching to sample task 48: assessment of malingering with simulating design. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2021;28(6):797\u2013811.","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41398-024-03118-0","article-title":"Davunetide sex-dependently boosts memory in prodromal Alzheimer's disease","volume":"14","author":"Gozes I","year":"2024","unstructured":"Gozes I, Blatt J, Lobyntseva A. Davunetide sex-dependently boosts memory in prodromal Alzheimer's disease. Transl Psychiatry. 2024;14(1):412.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12877-022-02853-7","article-title":"Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment","volume":"22","author":"Huang Y","year":"2022","unstructured":"Huang Y, Huang L, Wang Y, Liu Y, Lo CZ, Guo Q. Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment. BMC Geriatr. 2022;22(1):153.","journal-title":"BMC Geriatr"},{"issue":"4","key":"ref75","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(84)90003-4","article-title":"Effects of aging and dementia upon recent visuospatial memory","volume":"5","author":"Flicker C","year":"1984","unstructured":"Flicker C, Bartus RT, Crook TH, Ferris SH. Effects of aging and dementia upon recent visuospatial memory. Neurobiol Aging. 1984;5(4):275\u201383.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"ref76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/03610738708259313","article-title":"A visual recognition memory test for the assessment of cognitive function in aging and dementia","volume":"13","author":"Flicker C","year":"1987","unstructured":"Flicker C, Ferris SH, Crook T, Bartus RT. A visual recognition memory test for the assessment of cognitive function in aging and dementia. Exp Aging Res. 1987;13(3):127\u201332.","journal-title":"Exp Aging Res"},{"issue":"6","key":"ref77","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/13803395.2016.1147530","article-title":"Alzheimer's disease and memory strength: Gradual decline of memory traces as a function of their strength","volume":"38","author":"Vallet GT","year":"2016","unstructured":"Vallet GT, Rouleau I, Benoit S, Langlois R, Barbeau EJ, Joubert S. Alzheimer's disease and memory strength: Gradual decline of memory traces as a function of their strength. J Clin Exp Neuropsychol. 2016;38(6):648\u201360.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"4","key":"ref78","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1037\/a0028485","article-title":"Improving delayed face recognition in Alzheimer's disease by differential outcomes","volume":"26","author":"Plaza V","year":"2012","unstructured":"Plaza V, Lopez-Crespo G, Antunez C, Fuentes LJ, Estevez AF. Improving delayed face recognition in Alzheimer's disease by differential outcomes. Neuropsychology. 2012;26(4):483\u20139.","journal-title":"Neuropsychology"},{"issue":"8","key":"ref79","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1212\/01.WNL.0000120548.24298.DB","article-title":"Evaluation of visual recognition memory in MCI patients","volume":"62","author":"Barbeau E","year":"2004","unstructured":"Barbeau E, Didic M, Tramoni E, Felician O, Joubert S, Sontheimer A, Ceccaldi M, Poncet M. Evaluation of visual recognition memory in MCI patients. Neurology. 2004;62(8):1317\u201322.","journal-title":"Neurology"},{"year":"2017","author":"Bustos FJ","key":"ref80","unstructured":"Bustos FJ, Ampuero E, Jury N, Aguilar R, Falahi F, Toledo J, Ahumada J, Lata J, Cubillos P, Henriquez B, Guerra MV, Stehberg J, Neve RL, Inestrosa NC, Wyneken U, Fuenzalida M, Hartel S, Sena-Esteves M, Varela-Nallar L, Rots MG, Montecino M, van Zundert B. (2017). Epigenetic editing of the Dlg4\/PSD95 gene improves cognition in aged and Alzheimer's disease mice. Brain, 140(12), 3252\u20133268."},{"issue":"6","key":"ref81","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ana.24394","article-title":"Fyn inhibition rescues established memory and synapse loss in Alzheimer mice","volume":"77","author":"Kaufman AC","year":"2015","unstructured":"Kaufman AC, Salazar SV, Haas LT, Yang J, Kostylev MA, Jeng AT, Robinson SA, Gunther EC, van Dyck CH, Nygaard HB, Strittmatter SM. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann Neurol. 2015;77(6):953\u201371.","journal-title":"Ann Neurol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7007-6-37","article-title":"Erythropoietin enhances hippocampal long-term potentiation and memory","volume":"6","author":"Adamcio B","year":"2008","unstructured":"Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F, Zhang M, Muller M, Hassouna I, Hannke K, Sperling S, Radyushkin K, El-Kordi A, Schulze L, Ronnenberg A, Wolf F, Brose N, Rhee JS, Zhang W, Ehrenreich H. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol. 2008;6:37.","journal-title":"BMC Biol"},{"issue":"11","key":"ref83","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1021\/acs.molpharmaceut.8b00594","article-title":"Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease","volume":"15","author":"Chang R","year":"2018","unstructured":"Chang R, Maghribi A, Vanderpoel A, Vasilevko V, Cribbs V, Boado DH, Pardridge R, W. M., Sumbria RK. Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease. Mol Pharm. 2018;15(11):4963\u201373.","journal-title":"Mol Pharm"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neurobiolaging.2019.05.003","article-title":"Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology","volume":"81","author":"Dmytriyeva O","year":"2019","unstructured":"Dmytriyeva O, Belmeguenai A, Bezin L, Soud K, Drucker Woldbye DP, Gotzsche CR, Pankratova S. Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology. Neurobiol Aging. 2019;81:88\u2013101.","journal-title":"Neurobiol Aging"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pbb.2014.12.011","article-title":"Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease","volume":"130","author":"Esmaeili Tazangi P","year":"2015","unstructured":"Esmaeili Tazangi P, Moosavi SM, Shabani M, Haghani M. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease. Pharmacol Biochem Behav. 2015;130:15\u201321.","journal-title":"Pharmacol Biochem Behav"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2012.05.050","article-title":"Synaptic changes in Alzheimer's disease and its models","volume":"251","author":"Pozueta J","year":"2013","unstructured":"Pozueta J, Lefort R, Shelanski ML. Synaptic changes in Alzheimer's disease and its models. Neuroscience. 2013;251:51\u201365.","journal-title":"Neuroscience"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2015.05.031","article-title":"Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid beta42 in mice","volume":"1618","author":"Li YP","year":"2015","unstructured":"Li YP, Yang GJ, Jin L, Yang HM, Chen J, Chai GS, Wang L. Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid beta42 in mice. Brain Res. 2015;1618:159\u201367.","journal-title":"Brain Res"},{"issue":"1","key":"ref88","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-160500","article-title":"An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease","volume":"55","author":"Rodriguez Cruz Y","year":"2017","unstructured":"Rodriguez Cruz Y, Strehaiano M, Obaya R, Garcia Rodriguez T, J. C., Maurice T. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease. J Alzheimer's disease: JAD. 2017;55(1):231\u201348.","journal-title":"J Alzheimer's disease: JAD"},{"issue":"1","key":"ref89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function","volume":"8","author":"Cleary JP","year":"2005","unstructured":"Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function. Nat Neurosci. 2005;8(1):79\u201384.","journal-title":"Nat Neurosci"},{"issue":"6","key":"ref90","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean CA","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol. 1999;46(6):860\u20136.","journal-title":"Ann Neurol"},{"issue":"12","key":"ref91","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline","volume":"283","author":"Naslund J","year":"2000","unstructured":"Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 2000;283(12):1571\u20137.","journal-title":"JAMA"},{"issue":"2","key":"ref92","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbr.2008.06.001","article-title":"Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures","volume":"193","author":"Poling A","year":"2008","unstructured":"Poling A, Morgan-Paisley K, Panos JJ, Kim EM, O'Hare E, Cleary JP, Lesne S, Ashe KH, Porritt M, Baker LE. Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures. Behav Brain Res. 2008;193(2):230\u20134.","journal-title":"Behav Brain Res"},{"issue":"12","key":"ref93","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.neurobiolaging.2010.01.011","article-title":"Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors","volume":"32","author":"Ronicke R","year":"2011","unstructured":"Ronicke R, Mikhaylova M, Ronicke S, Meinhardt J, Schroder UH, Fandrich M, Reiser G, Kreutz MR, Reymann KG. Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol Aging. 2011;32(12):2219\u201328.","journal-title":"Neurobiol Aging"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease","volume":"9","author":"Tu S","year":"2014","unstructured":"Tu S, Okamoto S, Lipton SA, Xu H. Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease. Mol neurodegeneration. 2014;9:48.","journal-title":"Mol neurodegeneration"},{"issue":"2","key":"ref95","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/mt.2015.198","article-title":"Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma","volume":"24","author":"Bond WS","year":"2016","unstructured":"Bond WS, Hines-Beard J, GoldenMerry YL, Davis M, Farooque A, Sappington RM, Calkins DJ, Rex TS. Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma. Mol Ther. 2016;24(2):230\u20139.","journal-title":"Mol Ther"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6465973\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6465973\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T20:23:18Z","timestamp":1745266998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6465973\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":95,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6465973\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,4,18]]},"subtype":"preprint"}}